Jef Focant

Jef Focant on whether workflows transfer between biological matrices, and which holds the most promise for minimally invasive disease monitoring.

Jef Focant considers how far we are from fully automated, standardized GC×GC data processing pipelines accessible to labs without specialist chromatography knowledge.

Jef Focant on what methodological and study design changes will drive volatolomics from promising biomarker discovery results to clinically actionable tests.

Jef Focant discusses where comprehensive two-dimensional gas chromatography fits in a clinical setting increasingly demanding rapid, low-cost diagnostic solutions.